Novartis AG Common Stock (NVS)

Cash & Short-Term Investments

$7.69B

Quarterly · Period ending: · USD

NVS logo

NVS Cash & Short-Term Investments

Latest reported$7.69B
NVS Quarterly Cash & Short-Term Investments ($12.94B → $7.69B)
High-resolution chart · PNG

NVS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
7,690,031,000
6,977,000,000
11,590,020,000
9,753,000,000
7,000,000,000
7,196,000,000
13,351,000,000
14,020,000,000
8,435,000,000
9,694,000,000
14,427,971,591
12,695,000,000
11,174,000,000
12,260,000,000
18,930,045,810
19,103,000,000
19,758,000,000
18,814,000,000
28,329,000,000
8,162,000,000
5,356,000,000
4,077,000,000
11,563,000,000
10,870,000,000
6,293,000,000
4,973,000,000
11,445,950,530
8,717,000,000
10,335,000,000
7,112,000,000
15,964,000,000
14,710,000,000
13,146,000,000
6,422,000,000
9,485,000,000
9,421,000,000
8,437,000,000
8,237,000,000
7,777,000,000
7,785,000,000
5,740,000,000
5,086,000,000
5,447,000,000
6,064,000,000
5,875,000,000
7,363,000,000
13,862,000,000
10,427,000,000
7,335,000,000
7,721,000,000
9,222,000,000
7,339,000,000
5,250,000,000
6,035,000,000
8,119,000,000
0
0
0
5,075,000,000
0
0
0
8,134,000,000
0
0
0
17,449,000,000
0
0
0
6,117,000,000
8,137,000,000
16,198,000,000
10,850,000,000
13,201,000,000
14,532,000,000
7,548,000,000
6,957,000,000
7,955,000,000
8,530,000,000
7,310,000,000
11,117,000,000
10,933,000,000
7,947,000,000
9,440,000,000
12,282,000,000
14,593,000,000
12,185,000,000
12,301,000,000
12,106,000,000
13,259,000,000
11,851,000,000
11,137,000,000
12,896,000,000
12,575,000,000
10,331,000,000
12,905,000,000
13,183,000,000
8,405,000,000
12,514,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.